We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open1,810
High1,838.9
Low1,803.3
Prev. Close1,805.5
Avg. Traded Price1,828.03
Volume6,48,418

MARKET DEPTH

info2
Total bid1,20,176.00
Total ask1,57,945.00
OrdersQtyBid
62501830.9
1121830.8
131830.7
51131830.6
4611830.5
AskQtyOrders
1831.325
1831.411
1831.5111
1831.7334
1831.88159

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

1,803.303 hours ago
1,838.902 hours ago
arrow

LOWER/UPPER CIRCUITS

1,625.00
1,986.00
arrow
Sun Pharmaceutical Industries Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 11.97%, in the last year to ₹49,851.04 Cr. Its sector's average revenue growth for the last fiscal year was 12.27%.
noteAnnual Net Profit,rose 13.01% in the last year to ₹9,576.38 Cr. Its sector's average net profit growth for the last fiscal year was 29.44%.
notePrice to Earning Ratio,is 37.86, lower than its sector PE ratio of 41.54.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 27.61%
Net profit growth 5Y CAGR : 24.63%

STOCK RETURNS

info
Versus Nifty 50
1 w
+2.44%
vs
-0.36%
1 mth
+3.04%
vs
+2.21%
3 mth
+4.80%
vs
+4.71%
6 mth
-6.07%
vs
-1.23%
1 yr
+17.47%
vs
+6.16%
3 yr
+94.07%
vs
+39.4%
5 yr
+277.13%
vs
+156.26%

ANALYST RATING

Aggregated across 100 coverages
Buy
Hold
Sell
75%
25%
0%
Powered by Trendlyne.
Sun Pharmaceutical Industries Ltd Top mutual funds holding
arrow
Sun Pharmaceutical Industries Limited is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult to make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and Intermediates. Its broad portfolio of thousands of high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids.
personal

Grow your wealth with more research recommendations

+91